Please login to the form below

Not currently logged in
Email:
Password:

Almirall appoints Peter Guenter as its CEO

He joins from Sanofi where he was executive vice president

Peter GuenterAlmirall has appointed Peter Guenter as its new chief executive officer, succeeding Eduardo Sanchiz who leaves to spend more time dedicated to other interests.

Guenter joins from Sanofi, where he has worked for the past 22 years, most recently as executive vice president diabetes and cardiovascular global business unit.

He said: “I am excited and eager to join Almirall as CEO. The company has a clearly defined strategy, putting the patients and customers at the centre of everything we do.

“Together with my team, I am convinced we will be able to fully unlock the value of Almirall.”

He previously held many senior positions at Sanofi, including vice president Eastern Europe and Northern Europe, vice president business management and support, general manager, Germany, and senior vice president, Europe.

Jorge Gallardo, chairman of the board, Almirall, said: “I am particularly satisfied that we have been able to attract Peter to Almirall.

“He is a truly global leader and brings a wealth of experience in US, Europe, and emerging markets. I am convinced he will bring what is needed to develop Almirall to the next level.”

Sanchiz will hand over the leadership of Almirall to Guenter during September.

30th August 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Conversis

Conversis is a translation company specialising in translation and localisation for the Life Science and Pharmaceutical industry, with particular focus...

Latest intelligence

Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...
The Holy Grail of HCP Access
This is the data you need to gain access....

Infographics